{"entity":{"id":"nct00002872","kind":"trial","name":"Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions","aka":[],"tldr":"A phase 3 trial of Bleomycin and Talc in Metastatic cancer, run by Eastern Cooperative Oncology Group, completed.","summary":"Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions is a phase 3 interventional study registered as NCT00002872 by Eastern Cooperative Oncology Group, with 480 participants recorded, started 1997-01-10 and reaching its primary completion in 2003-02. Interventions recorded: bleomycin sulfate, doxycycline, talc. Conditions recorded: Metastatic Cancer.\n\nLinked to the drug Talc because the registry names it among its interventions and Metastatic cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00002872","url":"https://clinicaltrials.gov/study/NCT00002872"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["bleomycin","talc-sclerosant"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00002872","phase":"3","setting":"A PROSPECTIVE RANDOMIZED TRIAL OF BLEOMYCIN VS. DOXYCYCLINE VS. TALC FOR THE INTRAPLEURAL TREATMENT OF MALIGNANT PLEURAL EFFUSIONS","sponsor":"Eastern Cooperative Oncology Group","enrolled":480,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00002872/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"bleomycin","kind":"drug","name":"Bleomycin","route":"/drugs/bleomycin/"},{"id":"talc-sclerosant","kind":"drug","name":"Talc (intrapleural)","route":"/drugs/talc-sclerosant/"}]}}